Benign Prostatic Hyperplasia 

Through Pleiotropic effects such as GnRH antagonist, 5-α reductase inhibitor of GV1001, we have confirmed improvements in International Prostate Symptom Score (IPSS), urination rate, reduced residual urine volume, and no side effects (sexual dysfunction) in clinical trials. 

Alzheimer’s disease

Pleiotropic Effects such as anti-inflammatory, ROS production suppression, and brain cell death inhibition of GV1001 confirmed positive effects in clinical trials on various indicators such as Severe Impairment Battery (SIB) and Neuropsychiatric Inventory (NPI). 

Age-related diseases 

We are developing a variety of Senile diseases treatment through Pleiotropic effects such as anti-inflammatory, antioxidant, and cell protection. 

Chronic inflammation diseases 

We are developing various inflammation-related disease treatments through Pleiotropic effects such as anti-inflammatory and antioxidant. 

Cancer Immunotherapy 

T cells, recognizing GV1001 by antigen-presenting cells through human immune response, identify the telomerase that cancer cells overexpress and eliminate cancer cells.